Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Laurion Capital Management

Investor type Hedge Fund

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 17
Average round size
info
The average size of a deal this fund participated in
$111M
Portfolio companies 16
Rounds per year 1.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.06
Exits 4
Key employees 4

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Artificial Intelligence
Summary

The overall number of key employees were 4.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Laurion Capital Management, startups are often financed by Bill & Melinda Gates Foundation, WuXi AppTec, Scott Becker. The meaningful sponsors for the fund in investment in the same round are Samsara BioCapital, Pfizer Venture Investments, Perceptive Advisors.

The top activity for fund was in 2019. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in 2-6 deals per year.

Among the most popular fund investment industries, there are Enterprise Software, Biotechnology. Besides, a startup requires to be at the age of more than 20 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Schrodinger.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Laurion Capital Management:
Typical Co-investors
Laurion Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Laurion Capital Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Broadview Ventures Boston, Massachusetts, United States
Caltech California, Pasadena, United States
Elysian Park Ventures California, Los Angeles, United States
Hollinger Digital Inc. New York, New York, United States
Juniper Networks California, Sunnyvale, United States
New Media Ventures California, San Francisco, United States
Regional Cancer Care Associates Hackensack, New Jersey, United States
Sanwa Butsuryu Service Hokkaido Prefecture, Japan, Sapporo
Valley Growth Ventures Ohio, United States, Youngstown
WME Ventures New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Solid Biosciences

Biotechnology
Genetics
Health Care
Medical
$75M30 Sep 2022 Marlborough, Massachusetts, United States

RayzeBio

Biotechnology
Health Care
Medical Device
Pharmaceutical
$160M13 Sep 2022 San Diego, California, United States

MerQube

Cloud Computing
Cloud Infrastructure
Financial Services
FinTech
Information Services
$8M03 Aug 2022 San Francisco, California, United States

TRex Bio

Bioinformatics
Biopharma
Biotechnology
$26M08 Mar 2022 South San Francisco, California, United States

Scipher Medicine

Alternative Medicine
Artificial Intelligence
Biotechnology
Health Care
Health Diagnostics
$110M24 Feb 2022 Massachusetts, United States

Synthego

Biotechnology
Discovery Tools (Healthcare)
Genetics
Industrial Automation
Innovation Management
Life Science
Machine Learning
Software
$200M17 Feb 2022 Redwood City, California, United States

Ambys Medicines

Biotechnology
Medical
Therapeutics
$47M21 Dec 2021 -

AnHeart Therapeutics

Biotechnology
$61M14 Dec 2021 Shangcheng District, Zhejiang, China

Racket.com

Audio
Internet Radio
Podcast
Social Media
$3M16 Nov 2021 Los Angeles, California, United States
News
Exscientia Raises Up To $525M in Funding

– Exscientia is an Oxford, England, UK-based clinical stage pharmatech company using AI to design patient-based drugs.
SoftBank Vision Fund 2 led the Series D funding round and was joined by previous round lead investors – Novo Holdings and funds managed by Blackrock.
– Other investors included Mubadala Investment Company, Farallon Capital, Casdin Capital, GT Healthcare Capital, Marshall Wace, Pivotal bioVenture Partners, Laurion Capital, Hongkou and Bristol-Myers Squibb.
– In addition to the Series D funding round, SoftBank is providing an additional $300m equity commitment that can be drawn at the company’s discretion.

Pyxis Oncology Raises $152M Series B Round

– Pyxis Oncology from Longwood Fund has closed a $152m Series B financing.
– The round was led by Arix Bioscience and co-led by RTW Investments, LP.
– New investors included Perceptive Advisors, RA Capital Management, Pfizer Ventures, BVF Partners, L.P., Janus Henderson Investors, Cormorant Asset Management, HBM Healthcare Investments, funds managed by Tekla Capital Management LLC, Acuta Capital Partners, Ridgeback Capital Investments, Surveyor Capital (a Citadel company), Laurion Capital Management, Logos Capital and LifeSci Venture Partners.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Laurion Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: